Literature DB >> 19734288

Pseudoclavibacter chungangensis sp. nov., isolated from activated sludge.

Sung-Lim Cho1, Min Young Jung2,1, Mi-Hak Park1, Young-Hyo Chang2, Jung-Hoon Yoon2, Soon Chul Myung3, Wonyong Kim1.   

Abstract

The taxonomic position of a Gram-positive, non-spore-forming strain, designated CAU 59(T), from activated sludge was investigated. Colony morphology, biochemical tests and chemotaxonomic investigations revealed that strain CAU 59(T) possessed the characteristics of the genus Pseudoclavibacter. Comparative 16S rRNA gene sequence analysis showed sequence divergence values between strain CAU 59(T) and other described Pseudoclavibacter species of more than 3.6 %, and the strain formed a hitherto-unknown subline within the genus Pseudoclavibacter. DNA-DNA hybridization studies showed that strain CAU 59(T) displayed 20.9 % relatedness to its closest phylogenetic neighbour, Pseudoclavibacter helvolus DSM 20419(T). The DNA G+C content was 66.2 mol%. The phenotypic, chemotaxonomic and genotypic data indicated that strain CAU 59(T) represents a novel species of the genus Pseudoclavibacter, for which the name Pseudoclavibacter chungangensis sp. nov. is proposed. The type strain is CAU 59(T) (=KCTC 22691(T) =CCUG 58142(T)).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734288     DOI: 10.1099/ijs.0.015552-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  5 in total

1.  First report of endocarditis caused by a Pseudoclavibacter species.

Authors:  Hélène Pailhoriès; Carole Lemarié; Catherine Quinqueneau; Matthieu Eveillard; Christophe Baufreton; Frédéric Rouleau; Chetaou Mahaza; Marie-Laure Joly-Guillou; Marie Kempf
Journal:  J Clin Microbiol       Date:  2014-07-02       Impact factor: 5.948

Review 2.  Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory.

Authors:  Deirdre L Church; Lorenzo Cerutti; Antoine Gürtler; Thomas Griener; Adrian Zelazny; Stefan Emler
Journal:  Clin Microbiol Rev       Date:  2020-09-09       Impact factor: 26.132

3.  First case of Pseudoclavibacter bifida bacteremia in an immunocompromised host with chronic obstructive pulmonary disease (COPD).

Authors:  Matthijs Oyaert; Thierry De Baere; Joke Breyne; Emmanuel De Laere; Stan Mariën; Peter Waets; Wim Laffut
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

4.  Description of Pseudoclavibacter triregionum sp. nov. from human blood and Pseudoclavibacter albus comb. nov., and revised classification of the genus Pseudoclavibacter: proposal of Caespitibacter gen. nov., with Caespitibacter soli comb. nov. and Caespitibacter caeni comb. nov.

Authors:  Peter Vandamme; Charlotte Peeters; Helena M B Seth-Smith; Hanna Schmid; Margo Cnockaert; Adrian Egli; Daniel Goldenberger
Journal:  Antonie Van Leeuwenhoek       Date:  2022-02-02       Impact factor: 2.271

5.  Pseudoclavibacter otitis media in a 3-year-old boy with pulmonary and spinal tuberculosis.

Authors:  Satja Issaranggoon Na Ayuthaya; Amornrut Leelaporn; Pattarachai Kiratisin; Peninnah Oberdorfer
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.